Disruption of innate defense responses by endoglycosidase HPSE promotes cell survival.


Journal

JCI insight
ISSN: 2379-3708
Titre abrégé: JCI Insight
Pays: United States
ID NLM: 101676073

Informations de publication

Date de publication:
08 04 2021
Historique:
received: 14 09 2020
accepted: 18 02 2021
pubmed: 24 2 2021
medline: 21 1 2022
entrez: 23 2 2021
Statut: epublish

Résumé

The drive to withstand environmental stresses and defend against invasion is a universal trait extant in all forms of life. While numerous canonical signaling cascades have been characterized in detail, it remains unclear how these pathways interface to generate coordinated responses to diverse stimuli. To dissect these connections, we followed heparanase (HPSE), a protein best known for its endoglycosidic activity at the extracellular matrix but recently recognized to drive various forms of late-stage disease through unknown mechanisms. Using herpes simplex virus-1 (HSV-1) infection as a model cellular perturbation, we demonstrate that HPSE acts beyond its established enzymatic role to restrict multiple forms of cell-intrinsic defense and facilitate host cell reprogramming by the invading pathogen. We reveal that cells devoid of HPSE are innately resistant to infection and counteract viral takeover through multiple amplified defense mechanisms. With a unique grasp of the fundamental processes of transcriptional regulation and cell death, HPSE represents a potent cellular intersection with broad therapeutic potential.

Identifiants

pubmed: 33621216
pii: 144255
doi: 10.1172/jci.insight.144255
pmc: PMC8119219
doi:
pii:

Substances chimiques

Interferon Type I 0
Transcription Factors 0
heparanase EC 3.2.1.-
Glucuronidase EC 3.2.1.31

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : R21 AI133557
Pays : United States
Organisme : NEI NIH HHS
ID : P30 EY001792
Pays : United States
Organisme : NIMH NIH HHS
ID : R25 MH086466
Pays : United States
Organisme : NIAMS NIH HHS
ID : T32 AR064194
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI128171
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI139768
Pays : United States
Organisme : NEI NIH HHS
ID : F30 EY025981
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY029426
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY024710
Pays : United States

Références

J Virol. 1999 May;73(5):4493-7
pubmed: 10196354
Cancer Res. 2009 Mar 1;69(5):1758-67
pubmed: 19244131
Oncogene. 2015 Nov 19;34(47):5832-42
pubmed: 25745999
Nat Methods. 2011 Oct 02;8(11):937-40
pubmed: 21963607
Immunity. 2006 Sep;25(3):349-60
pubmed: 16979567
Mol Cancer Res. 2016 Dec;14(12):1243-1253
pubmed: 27565180
Sci Rep. 2017 Mar 23;7(1):325
pubmed: 28336942
Nat Methods. 2007 Mar;4(3):207-14
pubmed: 17327847
EMBO J. 1998 Feb 16;17(4):1087-95
pubmed: 9463386
Lab Invest. 2004 May;84(5):535-44
pubmed: 15034597
Nat Rev Neurosci. 2010 Aug;11(8):539-51
pubmed: 20648061
Nat Med. 2012 Aug;18(8):1224-31
pubmed: 22820642
Int J Oncol. 2012 Feb;40(2):494-500
pubmed: 22001963
J Clin Invest. 2008 Oct;118(10):3470-7
pubmed: 18769632
Bioinformatics. 2009 Apr 15;25(8):1091-3
pubmed: 19237447
Future Virol. 2011 Apr;6(4):421-429
pubmed: 21765858
Proc Natl Acad Sci U S A. 2009 Nov 10;106(45):19132-7
pubmed: 19850872
Oncogenesis. 2016 Feb 29;5:e202
pubmed: 26926788
Inflammation. 2017 Dec;40(6):1912-1923
pubmed: 28752362
Ocul Surf. 2019 Jan;17(1):40-49
pubmed: 30317007
Nat Rev Mol Cell Biol. 2001 Aug;2(8):599-609
pubmed: 11483993
Proteomics. 2011 May;11(10):2019-26
pubmed: 21500348
OMICS. 2012 May;16(5):284-7
pubmed: 22455463
Bioinformatics. 2009 Feb 15;25(4):435-42
pubmed: 19073590
J Virol. 1987 Mar;61(3):829-39
pubmed: 3027408
Prog Retin Eye Res. 2013 Jan;32:88-101
pubmed: 22944008
J Virol. 1998 Sep;72(9):7563-8
pubmed: 9696854
J Virol. 2016 Jan 20;90(7):3558-72
pubmed: 26792742
PLoS Pathog. 2016 Jul 14;12(7):e1005738
pubmed: 27416066
PLoS One. 2009;4(4):e5181
pubmed: 19360105
Mol Cell Proteomics. 2017 Aug;16(8):1447-1461
pubmed: 28606917
Cancer Sci. 2007 Apr;98(4):535-40
pubmed: 17284253
Nat Rev Microbiol. 2018 Jul;16(7):423-439
pubmed: 29769653
World J Virol. 2016 Nov 12;5(4):144-154
pubmed: 27878101
J Biol Chem. 2005 Oct 21;280(42):35136-47
pubmed: 16093249
J Virol. 2012 Aug;86(16):8559-67
pubmed: 22647700
Cell. 1996 Nov 1;87(3):427-36
pubmed: 8898196
Front Microbiol. 2018 Sep 27;9:2326
pubmed: 30319594
Trends Biochem Sci. 2018 Jan;43(1):18-31
pubmed: 29162390
Proc Natl Acad Sci U S A. 2014 Aug 5;111(31):E3206-13
pubmed: 25049377
Transcription. 2012 May-Jun;3(3):130-45
pubmed: 22771948
J Immunol. 2012 Sep 15;189(6):3104-11
pubmed: 22904301
Microbiome. 2018 Feb 13;6(1):32
pubmed: 29439731
Cell Rep. 2017 Jul 11;20(2):439-450
pubmed: 28700944
Trends Neurosci. 2005 Aug;28(8):436-45
pubmed: 15982754
Virus Res. 2018 Sep 2;256:29-37
pubmed: 30077727
Nat Commun. 2015 Apr 27;6:6985
pubmed: 25912399
Bioinformatics. 2011 Sep 1;27(17):2463-4
pubmed: 21737437
J Virol. 2017 Jul 12;91(15):
pubmed: 28490587
Adv Exp Med Biol. 2020;1221:759-770
pubmed: 32274736
Oncogene. 2018 May;37(20):2728-2745
pubmed: 29511351
Adv Exp Med Biol. 2020;1221:3-59
pubmed: 32274705
Oncol Res. 2017 Apr 14;25(4):511-522
pubmed: 27733217
Annu Rev Immunol. 2014;32:513-45
pubmed: 24555472
J Immunol. 2010 Nov 1;185(9):5211-24
pubmed: 20861348
J Biol Chem. 2016 Mar 25;291(13):6714-22
pubmed: 26851278
EMBO J. 2017 Sep 1;36(17):2529-2543
pubmed: 28716805
Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):E3109-18
pubmed: 23898178

Auteurs

Alex Agelidis (A)

Department of Microbiology and Immunology.
Department of Ophthalmology and Visual Sciences, and.

Benjamin A Turturice (BA)

Department of Microbiology and Immunology.
Division of Pulmonary, Critical Care, Sleep, and Allergy, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA.

Rahul K Suryawanshi (RK)

Department of Ophthalmology and Visual Sciences, and.

Tejabhiram Yadavalli (T)

Department of Ophthalmology and Visual Sciences, and.

Dinesh Jaishankar (D)

Department of Ophthalmology and Visual Sciences, and.
Department of Dermatology, Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, USA.

Joshua Ames (J)

Department of Microbiology and Immunology.
Department of Ophthalmology and Visual Sciences, and.

James Hopkins (J)

Department of Microbiology and Immunology.
Department of Ophthalmology and Visual Sciences, and.

Lulia Koujah (L)

Department of Microbiology and Immunology.
Department of Ophthalmology and Visual Sciences, and.

Chandrashekhar D Patil (CD)

Department of Ophthalmology and Visual Sciences, and.

Satvik R Hadigal (SR)

Department of Ophthalmology and Visual Sciences, and.

Evan J Kyzar (EJ)

Department of Psychiatry, University of Illinois at Chicago, Chicago, Illinois, USA.

Anaamika Campeau (A)

Department of Pharmacology and.
Skaggs School of Pharmacy, UCSD, San Diego, La Jolla, California, USA.

Jacob M Wozniak (JM)

Department of Pharmacology and.
Skaggs School of Pharmacy, UCSD, San Diego, La Jolla, California, USA.

David J Gonzalez (DJ)

Department of Pharmacology and.
Skaggs School of Pharmacy, UCSD, San Diego, La Jolla, California, USA.

Israel Vlodavsky (I)

Technion Integrated Cancer Center (TICC), Rappaport Faculty of Medicine, Technion, Haifa, Israel.

Jin-Ping Li (JP)

Department of Medical Biochemistry and Microbiology, University of Uppsala, Uppsala, Sweden.

David L Perkins (DL)

Division of Nephrology, Department of Medicine, and.
Department of Surgery, University of Illinois at Chicago, Chicago, Illinois, USA.

Patricia W Finn (PW)

Department of Microbiology and Immunology.
Division of Pulmonary, Critical Care, Sleep, and Allergy, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA.

Deepak Shukla (D)

Department of Microbiology and Immunology.
Department of Ophthalmology and Visual Sciences, and.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH